Agenus maintains a worldwide footprint through collaborations and partnerships with top pharmaceutical and biotechnology corporations in North America, Europe and Asia. Its agreements involve exploration and development collaborations, license preparations and co-development plans directed at accelerating the interpretation of novel immunotherapies